Dr. Jeffrey Buchhalter, M.D

NPI: 1982676714
Total Payments
$98,540
2024 Payments
$1,800
Companies
15
Transactions
56

Payment Breakdown by Category

Consulting$95,215 (96.6%)
Other$1,895 (1.9%)
Food & Beverage$1,384 (1.4%)
Travel$46.66 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $95,215 20 96.6%
Honoraria $1,895 1 1.9%
Food and Beverage $1,384 34 1.4%
Travel and Lodging $46.66 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Ultragenyx Pharmaceutical Inc. $74,032 1 $0 (2018)
Biocodex, Inc. $5,955 9 $0 (2023)
UCB SA $5,600 5 $0 (2024)
INSYS Therapeutics Inc $5,400 8 $0 (2018)
Neurocrine Biosciences, Inc. $4,507 4 $0 (2022)
Marinus Pharmaceuticals, Inc. $1,969 2 $0 (2023)
UCB, Inc. $233.93 3 $0 (2023)
Sunovion Pharmaceuticals Inc. $225.91 10 $0 (2019)
LivaNova USA, Inc. $183.01 3 $0 (2020)
UPSHER-SMITH LABORATORIES LLC $148.14 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,800 1 UCB SA ($1,800)
2023 $6,810 13 Biocodex, Inc. ($4,655)
2022 $4,033 4 Neurocrine Biosciences, Inc. ($3,000)
2021 $3,790 6 Neurocrine Biosciences, Inc. ($1,507)
2020 $1,215 2 UCB SA ($1,200)
2019 $240.54 9 Upsher-Smith Laboratories LLC ($82.16)
2018 $80,129 19 Ultragenyx Pharmaceutical Inc. ($74,032)
2017 $523.46 2 INSYS Therapeutics Inc ($400.00)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
01/26/2024 UCB SA Briviact (Drug) Consulting Fee Cash or cash equivalent $1,800.00 General
Category: Neurology
12/01/2023 UCB, Inc. Food and Beverage In-kind items and services $119.17 General
10/23/2023 Biocodex, Inc. DIACOMIT (Drug) Consulting Fee Cash or cash equivalent $2,463.50 General
Category: Antiepileptic
08/10/2023 Marinus Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,920.00 General
08/10/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $58.00 General
Category: Antiepileptic
07/06/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Antiepileptic
06/16/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $22.59 General
Category: Antiepileptic
06/07/2023 Marinus Pharmaceuticals, Inc. ZTALMY (Drug) Food and Beverage In-kind items and services $49.39 General
Category: SEIZURE DISORDERS
05/21/2023 UPSHER-SMITH LABORATORIES LLC VIGADRONE (Drug) Food and Beverage In-kind items and services $21.21 General
Category: NEUROLOGY
05/20/2023 UPSHER-SMITH LABORATORIES LLC VIGADRONE (Drug) Food and Beverage In-kind items and services $44.77 General
Category: NEUROLOGY
05/11/2023 Biocodex, Inc. DIACOMIT (Drug) Honoraria Cash or cash equivalent $1,895.00 General
Category: Antiepileptic
05/11/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $113.90 General
Category: Antiepileptic
05/11/2023 Biocodex, Inc. DIACOMIT (Drug) Travel and Lodging Cash or cash equivalent $46.66 General
Category: Antiepileptic
04/23/2023 Biocodex, Inc. DIACOMIT (Drug) Food and Beverage In-kind items and services $35.96 General
Category: Antiepileptic
12/16/2022 UCB SA Briviact (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: Neurology
10/14/2022 JAZZ PHARMACEUTICALS INC. EPIDIOLEX (Drug) Food and Beverage In-kind items and services $133.14 General
Category: NEUROLOGY
04/22/2022 Neurocrine Biosciences, Inc. Consulting Fee Cash or cash equivalent $1,500.00 General
04/06/2022 Neurocrine Biosciences, Inc. Consulting Fee Cash or cash equivalent $1,500.00 General
12/10/2021 Greenwich Biosciences, Inc. Epidiolex (Drug) Food and Beverage In-kind items and services $40.03 General
Category: Neurology
12/04/2021 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $6.73 General
11/09/2021 Neurocrine Biosciences, Inc. Consulting Fee Cash or cash equivalent $1,500.00 General
10/26/2021 Greenwich Biosciences, Inc. Epidiolex (Drug) Food and Beverage In-kind items and services $43.00 General
Category: Neurology
07/01/2021 BIOCODEX, INC. DIACOMIT (Drug) Consulting Fee Cash or cash equivalent $1,300.00 General
Category: Antiepileptic
01/06/2021 UCB SA Briviact (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: Neurology
04/07/2020 UCB SA Briviact (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: Neurology

About Dr. Jeffrey Buchhalter, M.D

Dr. Jeffrey Buchhalter, M.D is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982676714.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Buchhalter, M.D has received a total of $98,540 in payments from pharmaceutical and medical device companies, with $1,800 received in 2024. These payments were reported across 56 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($95,215).

Practice Information

Products in Payments

  • DIACOMIT (Drug) $5,955
  • Briviact (Drug) $5,600
  • APTIOM (Drug) $225.91
  • VNS Therapy (Device) $183.01
  • EPIDIOLEX (Drug) $133.14
  • Epidiolex (Drug) $105.53
  • VIGADRONE (vigabatrin) for Oral Solution (Drug) $82.16
  • VIGADRONE (Drug) $65.98
  • ZTALMY (Drug) $49.39
  • Fycompa (Drug) $29.84
  • ACTHAR (Biological) $14.19
  • (820) Cholbam (Drug) $3.48

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology with Special Qualifications in Child Neurology Doctors in Phoenix